CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Embera Neurotherapeutics — — —
60
36% 		7/17/2026 View Intelligence
Embil Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Emerald Health Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Emergent BioDefense Operations Lansing — — —
60
40% 		7/20/2026 View Intelligence
Emergo Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Emet Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Eminence Organic Skin Care — — —
60
42% 		7/20/2026 View Intelligence
Emjay Laboratories — — —
60
40% 		7/20/2026 View Intelligence
Empros Pharma — — —
60
36% 		7/17/2026 View Intelligence
Emzor Pharmaceutical Industries — — —
60
36% 		7/17/2026 View Intelligence
Enalare Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enanta Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Enb Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enceladus Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Encoded Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Encube Ethicals — — —
60
42% 		7/20/2026 View Intelligence
Encysive Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Endo Tools Therapeutics 1 trials — —
60
36% 		7/17/2026 View Intelligence
Endo USA — — —
60
42% 		7/20/2026 View Intelligence
Endo Usa A Keenova Therapeutics 12 trials — —
75
36% 		7/17/2026 View Intelligence
Endocell Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Endogena Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Energetix — — —
60
42% 		7/20/2026 View Intelligence
Energique — — —
60
42% 		7/20/2026 View Intelligence
Engage Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Engrail Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enlitisa (shanghai) Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Enliven Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enlivex Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enlivex Therapeutics Rdo — — —
60
36% 		7/17/2026 View Intelligence
Ennar Pharmaceuticals Af — — —
60
36% 		7/17/2026 View Intelligence
Ennovabio Australia Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Enovex Pharmacy — — —
60
36% 		7/17/2026 View Intelligence
Ensem Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Ensho Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Ensol Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Ensysce Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Entasis Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enteris Biopharma — — —
60
36% 		7/17/2026 View Intelligence
Entero Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enteron Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Enterprise Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Entos Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Entrada Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enveda Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enviro Specialty Chemicals — — —
60
40% 		7/20/2026 View Intelligence
Enviro Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Envisia Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Enyo Pharma — — —
60
36% 		7/17/2026 View Intelligence
Enzene Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Showing 2051 - 2100 of 6,643 companies